查询: 取消
免责声明:证券数据为本网搜集归纳,尽量保证及时准确,入市投资请以上市公司公布的正式公告为准。本网证券行情存在延时,交易请以交易所即时行情价格为准。所有数据仅供参考,据此入市风险自担。
药明康德(603259)研究和试验发展
上涨家数:19下跌家数:11平均涨幅:+1.33%
更新时间:2025-09-15 15:00
名称最新价(元)市盈率(倍)涨跌幅
昭衍新药41.65102.49+10.01%
康龙化成35.9046.21+6.37%
益诺思41.70159.11+4.56%
睿智医药13.97-50.34+4.25%
阳光诺和82.4058.16+3.78%
诺思格57.9939.21+3.37%
药石科技45.9254.77+3.35%
美迪西81.10-39.84+3.12%
奥浦迈53.67176.84+2.33%
药康生物18.7173.49+1.68%
和元生物8.10-16.79+1.63%
药明康德107.0022.93+1.45%
普蕊斯49.6437.12+1.29%
泰格医药61.77179.90+1.25%
博济医药10.97297.61+0.83%
近岸蛋白42.53-42.80+0.45%
万邦医药44.0551.24+0.36%
毕得医药70.1845.89+0.23%
泓博医药37.34201.49+0.11%
百花医药10.1387.93-0.10%
皓元医药74.9556.18-0.13%
中源协和25.16161.42-0.28%
义翘神州81.5083.54-0.46%
百诚医药62.00-36.83-0.48%
成都先导26.70117.30-0.60%
泰坦科技24.69231.20-0.80%
百普赛斯58.0064.50-1.64%
诺唯赞22.95-293.28-1.71%
阿拉丁12.7052.83-1.93%
南模生物56.72130.81-2.34%

转至药明康德(603259)行情首页

中财网版权所有(C) HTTP://WWW.CFi.CN